SCD5: Key Enzyme in Fatty Acid Oxidation (G79966)

Target Name: SCD5

NCBI ID: G79966

SCD5

SCD5: Key Enzyme in Fatty Acid Oxidation

SCD5, or stearoyl-CoA desaturase 2, is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the fatty acid oxidation pathway, which is a critical process that occurs in all eukaryotic cells to generate energy. SCD5 is involved in the conversion of omega-3 and omega-6 fatty acids into their more potent forms, which are then used by cells to produce various compounds, including carbon dioxide, water, and energy.

SCD5 is a protein that is expressed in most tissues throughout the body, including the brain, heart, liver, and muscle. It is also highly expressed in the placenta, which is responsible for providing nutrients and oxygen to the developing fetus. SCD5 is a critical enzyme in the fatty acid oxidation pathway, which is the primary source of energy for most eukaryotic cells.

The fatty acid oxidation pathway is a complex series of reactions that occur in the mitochondria. In this pathway, omega-3 and omega-6 fatty acids are converted into their more potent forms, which are then used by cells to produce various compounds, including carbon dioxide, water, and energy. SCD5 is the enzyme that catalyzes the conversion of omega-3 and omega-6 fatty acids into their more potent forms.

SCD5 is a protein that is highly expressed in the brain, and it is involved in the production of various compounds that are critical for brain function, including fatty acids. SCD5 is also involved in the production of other compounds that are important for brain development and function, including sphingomyelin and cholinesterase.

SCD5 is a protein that is highly expressed in the heart, and it is involved in the production of various compounds that are critical for heart function, including fatty acids. SCD5 is also involved in the production of other compounds that are important for heart development and function, including ATP and cGMP.

SCD5 is a protein that is highly expressed in the liver, and it is involved in the production of various compounds that are critical for liver function, including fatty acids. SCD5 is also involved in the production of other compounds that are important for liver development and function, including aspartate and glutamate.

SCD5 is a protein that is highly expressed in the muscle, and it is involved in the production of various compounds that are critical for muscle function, including fatty acids. SCD5 is also involved in the production of other compounds that are important for muscle development and function, including myosin and creatine kinase.

In conclusion, SCD5 is a protein that is highly expressed in various tissues throughout the body and is involved in the production of essential fatty acids, which are critical for various cellular functions. SCD5 is a potential drug target and a biomarker for various diseases, including fatty acid oxidation disorders, autoimmune diseases, and cardiovascular diseases. Further research is needed to fully understand the role of SCD5 in human health and to develop effective treatments for these conditions.

Protein Name: Stearoyl-CoA Desaturase 5

Functions: Stearoyl-CoA desaturase that utilizes O(2) and electrons from reduced cytochrome b5 to introduce the first double bond into saturated fatty acyl-CoA substrates. Catalyzes the insertion of a cis double bond at the delta-9 position into fatty acyl-CoA substrates including palmitoyl-CoA and stearoyl-CoA (PubMed:15610069, PubMed:15907797, PubMed:22745828). Gives rise to a mixture of 16:1 and 18:1 unsaturated fatty acids (PubMed:15610069, PubMed:15907797). Involved in neuronal cell proliferation and differentiation through down-regulation of EGFR/AKT/MAPK and Wnt signaling pathways (PubMed:22745828)

The "SCD5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCD5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets